(Q33368788)

English

Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia

scientific article

Statements

Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia (English)
Carmella van de Ven

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit